|
|
|
|
|||||
|
|
|
| Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter
|
| Ticker | Owner | Relationship | Date | Transaction | Cost  |
#Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 19 '25 | Sale | 0.67 | 10,712 | 7,177 | 305,892 | May 21 08:08 PM |
| NKTR | Zalevsky Jonathan | Officer | May 19 '25 | Proposed Sale | 0.67 | 10,712 | 7,191 | May 19 03:49 PM | |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 19 '25 | Sale | 1.01 | 10,300 | 10,403 | 316,604 | Feb 21 06:07 PM |
| NKTR | Zalevsky Jonathan | Officer | Feb 19 '25 | Proposed Sale | 1.01 | 10,300 | 10,391 | Feb 19 03:18 PM | |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Dec 19 '24 | Sale | 0.94 | 51,115 | 48,048 | 326,904 | Dec 20 08:33 PM |
| NKTR | Zalevsky Jonathan | Officer | Dec 19 '24 | Proposed Sale | 0.94 | 51,115 | 48,063 | Dec 19 03:12 PM | |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 19 '24 | Sale | 1.01 | 7,785 | 7,863 | 243,019 | Nov 20 08:37 PM |
| NKTR | Zalevsky Jonathan | Officer | Nov 19 '24 | Proposed Sale | 1.01 | 7,785 | 7,878 | Nov 19 04:10 PM | |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 19 '24 | Sale | 1.28 | 6,866 | 8,788 | 250,804 | Aug 20 09:15 PM |
| NKTR | Zalevsky Jonathan | Officer | Aug 19 '24 | Proposed Sale | 1.28 | 6,866 | 8,762 | Aug 19 03:45 PM | |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 17 '24 | Sale | 1.75 | 7,355 | 12,871 | 257,670 | May 20 09:13 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 20 '24 | Sale | 0.68 | 9,014 | 6,130 | 265,025 | Feb 22 08:19 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 17 '23 | Sale | 0.49 | 9,646 | 4,727 | 274,039 | Nov 20 09:02 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 16 '23 | Sale | 0.78 | 9,703 | 7,568 | 283,685 | Aug 17 08:08 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 16 '23 | Sale | 0.72 | 9,791 | 7,050 | 293,388 | May 17 08:29 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 16 '23 | Sale | 3.00 | 10,484 | 31,452 | 303,179 | Feb 17 09:00 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 16 '22 | Sale | 3.57 | 13,460 | 48,052 | 313,663 | Nov 18 06:05 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 18 '22 | Sale | 4.65 | 73,716 | 342,779 | 327,123 | Aug 19 06:27 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 16 '22 | Sale | 4.76 | 10,560 | 50,266 | 400,839 | Aug 17 07:41 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 16 '22 | Sale | 3.95 | 21,673 | 85,608 | 276,399 | May 17 09:40 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 16 '22 | Sale | 10.95 | 10,912 | 119,486 | 274,122 | Feb 18 06:20 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 16 '21 | Sale | 13.16 | 20,869 | 274,636 | 232,084 | Nov 17 06:11 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 16 '21 | Sale | 13.83 | 7,662 | 105,965 | 212,803 | Aug 18 07:04 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 17 '21 | Sale | 18.30 | 31,111 | 569,331 | 235,065 | May 19 07:08 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 16 '21 | Sale | 22.37 | 24,141 | 540,034 | 266,176 | Feb 18 07:07 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 23 '20 | Sale | 16.40 | 16,380 | 268,632 | 250,317 | Nov 25 06:09 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 16 '20 | Sale | 16.93 | 29,618 | 501,433 | 266,697 | Nov 18 07:08 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Aug 17 '20 | Sale | 19.67 | 26,200 | 515,354 | 296,315 | Aug 19 06:41 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | May 18 '20 | Sale | 22.51 | 4,558 | 102,601 | 322,515 | May 20 06:33 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Feb 18 '20 | Sale | 22.35 | 4,774 | 106,699 | 327,073 | Feb 20 06:39 PM |
| NKTR | Zalevsky Jonathan | Chief R&D Officer | Nov 18 '19 | Sale | 17.97 | 3,960 | 71,161 | 291,697 | Nov 20 07:07 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite